Home
Archive
Contact
Akshay Hanikhindi
Home
Akshay Hanikhindi
Filter by
Categories
Tags
Authors
Show all
All
Active Clinical Trials
From the Co-Chairs
Institution Spotlights
News in Brief
People
Special Topics
Trial Results
All
Acute myeloid leukemia
Advocacy
Anal cancer
Big data
Blood cancer
Breast cancer
Cancer
Cancer care delivery research
Cancer control
Cancer screening
Cancer surveillance
Cardiotoxicity
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Comis symposium
COVID-19
De-escalation
Diversity
Gallbladder cancer
Geriatric oncology
GI cancer
Group meeting
Head and neck cancer
Health equity
Immunotherapy
Leukemia
Lung cancer
Lung inflammation
Lymphoma
Melanoma
Mentorship
Mesothelioma
Multiple myeloma
Myeloma
NCORP
Pancreatic cancer
Pancreatic cyst
Pathology
Peripheral neuropathy
Personalized screening
Pneumonitis
Precision medicine
Prostate cancer
Racism
Radiology
Renal cell
Reproductive health
Sarcoma
Sexuality
Social determinants of health
Survivorship
Symptom control
Targeted therapy
Vaccination
All
Akshay Hanikhindi
Diane Dragaud
ecogacrinnews2
Katie Heller
wpengine
September 14, 2020
September 14, 2020
Categories
Trial Results
Trial Results: PALbociclib CoLlaborative Adjuvant Study (PALLAS)
A second interim analysis of this international adjuvant study for HR+, HER2- early breast cancer demonstrates that there is little chance of palbociclib reducing the risk of recurrence
![ECOG-ACRIN logo[19516]275x75](https://blog-ecog-acrin.org/wp-content/uploads/2021/03/ECOG-ACRIN-logo19516275x75.png)
